dsp 4 has been researched along with Dyskinesia, Drug-Induced in 4 studies
DSP 4: RN given refers to parent cpd
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Pretreatment with 5,7-dihydroxytryptamine (5,7-DHT) suppressed the allylnitrile-induced head twitching, and decreased the contents of 5-HT and 5-HIAA in almost all areas of the brain throughout the observation period, as well as the ratio of 5-HIAA/5-HT in the medulla oblongata plus pons from 1 to 30 days after dosing with allylnitrile." | 1.29 | Involvement of noradrenergic and 5-hydroxytryptaminergic systems in allylnitrile-induced head twitching. ( Hashimoto, K; Huang, J; Tanii, H, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shin, E | 1 |
| Rogers, JT | 1 |
| Devoto, P | 1 |
| Björklund, A | 1 |
| Carta, M | 1 |
| Wang, Y | 1 |
| Wang, HS | 1 |
| Wang, T | 1 |
| Huang, C | 1 |
| Liu, J | 1 |
| Pérez, V | 1 |
| Marin, C | 1 |
| Rubio, A | 1 |
| Aguilar, E | 1 |
| Barbanoj, M | 1 |
| Kulisevsky, J | 1 |
| Tanii, H | 1 |
| Huang, J | 1 |
| Hashimoto, K | 1 |
4 other studies available for dsp 4 and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
Topics: Adrenergic Agents; Adrenergic Neurons; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benz | 2014 |
L-DOPA-induced dyskinesia in a rat model of Parkinson's disease is associated with the fluctuational release of norepinephrine in the sensorimotor striatum.
Topics: Adrenergic Agents; Animals; Antiparkinson Agents; Benzylamines; Chromatography, High Pressure Liquid | 2014 |
Effect of the additional noradrenergic neurodegeneration to 6-OHDA-lesioned rats in levodopa-induced dyskinesias and in cognitive disturbances.
Topics: Animals; Benzylamines; Cognition Disorders; Dyskinesia, Drug-Induced; Levodopa; Locus Coeruleus; Mal | 2009 |
Involvement of noradrenergic and 5-hydroxytryptaminergic systems in allylnitrile-induced head twitching.
Topics: 5,7-Dihydroxytryptamine; Animals; Benzylamines; Dyskinesia, Drug-Induced; Head; Hydroxyindoleacetic | 1993 |